Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of ARKG's 39 holdings also in WDNA
20.2%
% of WDNA's 91 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
TWIST BIOSCIENCE CORP. | 6.1% | 3.4% | 3.4% |
|
CRISPR THERAPEUTICS AG | 7.3% | 1.8% | 1.8% |
 |
ALCOBRA LTD | 3.5% | 1.7% | 1.7% |
|
BEAM THERAPEUTICS, INC. | 3.9% | 1.4% | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 2.7% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to WDNA
|
CRISPR THERAPEUTICS AG | 5.5% |
|
RECURSION PHARMACEUTICALS, INC CLASS | 5.2% |
|
EXACT SCIENCES CORP | 4.4% |
|
ACCOLADE, INC. | 4.0% |
|
CAREDX, INC. | 3.7% |
|
SCHRODINGER, INC. | 3.7% |
|
TELADOC INC | 3.4% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
|
INTELLIA THERAPEUTICS, INC. | 3.0% |
|
VEEVA SYSTEMS INC-CLASS A | 2.8% |
ARKG Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
ELI LILLY & CO | -1.9% |
|
VERICEL CORPORATION | -1.7% |
|
AGIOS PHARMACEUTICALS INC | -1.6% |
|
CARIBOU BIOSCIENCES, INC. | -1.6% |
|
EDITAS MEDICINE, INC. | -1.6% |